PVAL vs. FPHAX

Last updated Jun 14, 2026

PVAL (Putnam Focused Large Cap Value ETF) and FPHAX (Fidelity Select Pharmaceuticals Portfolio) are both funds - PVAL is a Large Cap Value Equities fund actively managed by Putnam, while FPHAX is a Health & Biotech Equities fund managed by Fidelity. Over the past 5 years, PVAL returned 16.29%/yr vs 13.07%/yr for FPHAX. A 0.52 correlation means they provide meaningful diversification when combined. PVAL charges 0.55%/yr vs 0.75%/yr for FPHAX.

Performance

PVAL vs. FPHAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Putnam Focused Large Cap Value ETF (PVAL) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with PVAL having a 13.07% return and FPHAX slightly lower at 12.59%.

PVAL

• 1D: 1.06%
• 1M: 3.05%
• YTD: 13.07%
• 6M: 13.55%
• 1Y: 32.98%
• 3Y*: 23.14%
• 5Y*: 16.29%
• 10Y*: —

FPHAX

• 1D: 2.60%
• 1M: 8.67%
• YTD: 12.59%
• 6M: 14.65%
• 1Y: 39.44%
• 3Y*: 18.94%
• 5Y*: 13.07%
• 10Y*: 12.36%

*Multi-year figures are annualized to reflect compound growth (CAGR)

PVAL vs. FPHAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
PVAL Putnam Focused Large Cap Value ETF	13.07%	24.13%	19.30%	18.41%	-2.61%	11.77%
FPHAX Fidelity Select Pharmaceuticals Portfolio	12.59%	30.41%	9.39%	12.54%	0.94%	4.91%

Correlation

The correlation between PVAL and FPHAX is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.45
Correlation (3Y) Calculated over the trailing 3-year period	0.49
Correlation (5Y) Calculated over the trailing 5-year period	0.53
Correlation (All Time) Calculated using the full available price history since May 26, 2021	0.52

The correlation between PVAL and FPHAX has been stable across timeframes, ranging from 0.45 to 0.53 - a consistent structural relationship.

Return for Risk

PVAL vs. FPHAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PVAL

PVAL Risk / Return Rank: 90
PVAL Sharpe Ratio Rank: 93
PVAL Sortino Ratio Rank: 92
PVAL Omega Ratio Rank: 91
PVAL Calmar Ratio Rank: 88
PVAL Martin Ratio Rank: 88

FPHAX

FPHAX Risk / Return Rank: 73
FPHAX Sharpe Ratio Rank: 72
FPHAX Sortino Ratio Rank: 72
FPHAX Omega Ratio Rank: 62
FPHAX Calmar Ratio Rank: 90
FPHAX Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PVAL vs. FPHAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Putnam Focused Large Cap Value ETF (PVAL) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	PVAL	FPHAX	Difference
Sharpe ratio: Return per unit of total volatility	2.89	1.99	+0.90
Sortino ratio: Return per unit of downside risk	4.03	2.81	+1.22
Omega ratio: Gain probability vs. loss probability	1.52	1.34	+0.19
Calmar ratio: Return relative to maximum drawdown	4.45	3.91	+0.53
Martin ratio: Return relative to average drawdown	16.87	10.18	+6.69

PVAL vs. FPHAX - Sharpe Ratio Comparison

The current PVAL Sharpe Ratio is 2.89, which is higher than the FPHAX Sharpe Ratio of 1.99. The chart below compares the historical Sharpe Ratios of PVAL and FPHAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

PVAL vs. FPHAX - Drawdown Comparison

The maximum PVAL drawdown since its inception was -16.64%, smaller than the maximum FPHAX drawdown of -38.26%. Use the drawdown chart below to compare losses from any high point for PVAL and FPHAX.

Drawdown Indicators

	PVAL	FPHAX	Difference
Max Drawdown Largest peak-to-trough decline	-16.64%	-38.26%	+21.62%
Max Drawdown (1Y) Largest decline over 1 year	-7.22%	-10.33%	+3.11%
Max Drawdown (3Y) Largest decline over 3 years	-15.42%	-28.82%	+13.40%
Max Drawdown (5Y) Largest decline over 5 years	-16.64%	-28.82%	+12.18%
Max Drawdown (10Y) Largest decline over 10 years	—	-28.82%	—
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	-3.01%	-9.17%	+6.16%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.90%	3.96%	-2.06%

Volatility

PVAL vs. FPHAX - Volatility Comparison

The current volatility for Putnam Focused Large Cap Value ETF (PVAL) is 3.68%, while Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a volatility of 5.88%. This indicates that PVAL experiences smaller price fluctuations and is considered to be less risky than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PVAL	FPHAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.68%	5.88%	-2.20%
Volatility (6M) Calculated over the trailing 6-month period	8.57%	14.33%	-5.76%
Volatility (1Y) Calculated over the trailing 1-year period	11.12%	20.28%	-9.16%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.32%	18.07%	-2.75%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	15.25%	17.89%	-2.64%

PVAL vs. FPHAX - Expense Ratio Comparison

PVAL has a 0.55% expense ratio, which is lower than FPHAX's 0.75% expense ratio.

Dividends

PVAL vs. FPHAX - Dividend Comparison

PVAL's dividend yield for the trailing twelve months is around 0.97%, less than FPHAX's 4.94% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FPHAX Fidelity Select Pharmaceuticals Portfolio	4.94%	5.68%	1.90%	8.08%	5.18%	11.09%	8.85%	8.33%	1.65%	1.62%	1.07%	12.63%
PVAL Putnam Focused Large Cap Value ETF	0.97%	1.00%	1.34%	1.33%	0.59%	0.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both PVAL and FPHAX in my portfolio?

PVAL and FPHAX have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PVAL or FPHAX?

FPHAX has higher volatility (5.88%) compared to PVAL (3.68%). In terms of maximum drawdown, PVAL dropped -16.64% vs FPHAX's -38.26%.

Which has better risk-adjusted returns?

PVAL currently has the higher Sharpe Ratio (2.89 vs 1.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.